Status: current, Defined. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3880633010 | Product containing crizanlizumab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3880947012 | Crizanlizumab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Crizanlizumab-containing product | Is a | Selective adhesion molecule inhibitor-containing product | true | Inferred relationship | Some | ||
| Crizanlizumab-containing product | Is a | Immunoglobulin-containing product | true | Inferred relationship | Some | ||
| Crizanlizumab-containing product | Is a | Monoclonal antibody-containing product | true | Inferred relationship | Some | ||
| Crizanlizumab-containing product | Has active ingredient | Crizanlizumab | true | Inferred relationship | Some | 1 | |
| Crizanlizumab-containing product | Is a | Immunomodulator-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Crizanlizumab only product | Is a | True | Crizanlizumab-containing product | Inferred relationship | Some | |
| Crizanlizumab-containing product in parenteral dose form | Is a | True | Crizanlizumab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR